Psych Congress 2023 Brochure - 5

Choose YouR
eduCational
expeRienCe
2 World-Class
Preconferences
advanced
PsychoPharmacology:
four most exciting things
haPPening in Psychiatry
CO-CHAIR: RAKESH JAIN, MD
SPEAKERS: STEVEN CHAN, MD, MBA;
CHARLES RAISON, MD;
JONATHAN MEYER, MD;
VLADIMIR MALETIC, MD
introduction to
reProductive Psychiatry
and Perinatal mental
health
Foundational
State of
co-develoPed sessions with:
American Foundation for Suicide Prevention
co-develoPed sessions with:
International Society for Reproductive
Psychiatry
co-develoPed sessions with:
Depression and Bipolar Support Alliance
SOLVING CLINICAL CHALLENGES
Designed to provide practical solutions to some of
the most challenging patient cases, Solving Clinical
Challenges sessions put our most experienced faculty
on the spot to answer the question-what would you
Clinical Challenges
CO-CHAIRS: CRAIG CHEPKE, MD, DFAPA;
NICOLE CIRINO, MD, CST, PMH-C
SPEAKERS: MELANIE BARRETT, MD;
RACHEL DALTHORP, MD, MHSA;
GILLIAN FRIEDMAN, MD;
DANIELLE JOHNSON, MD, FAPA;
NICHELLE HAYNES, DO
new tHis year:
Preconferences will take place on the same
day the main conference begins.
add the Preconferences and maximum
credit PackaGe to Your reGistration to
Get the most value Per credit hour.
do? Exploring complex scenarios associated with real patients,
our clinical panel will interact and collaborate to share insights
and expertise on diagnostic challenges, psychopharmacologic
and psychotherapeutic approaches, and multidisciplinary care.
Practical take-aways will enable clinicians to apply advanced
approaches to similarly complex patients, enhancing overall care
delivery and optimizing patient outcomes.
Anxiety disorders
Major depressive disorder
Attention deficit/hyperactivity disorder
STATE OF THE SCIENCE
These sessions will provide a comprehensive
overview of currently available treatment
strategies for the following conditions:
Foundational
State of
Major depressive disorder
Alzheimer's and aging
Schizophrenia
Clinical Challenges
FOUNDATIONAL
A new feature at Psych Congress in 2023, each
Foundations in Psychopharmacology session will
dive deep into one specific therapeutic drug class,
such as antidepressants or antipsychotics. These
sessions are distinct in their foundational emphasis on both longstanding
medications often appropriate as first-line therapies,
as well as additional first-line options and adjunctive treatments.
Foundations sessions may be particularly valuable for early-career
psychopharmacologists and those looking for a detailed look at the
when and the why of medication selection as well as access-related
challenges and considerations that may affect treatment decisions.
The sessions will take a deep dive into the following medication
classes:
Foundational
State of
Clinical Challenges
Antidepressants
Antipsychotics
#Psychcongress2023 | national.Psychcongress.com | 800.205.8233 5
http://national.Psychcongress.com
Psych Congress 2023 Brochure

Table of Contents for the Digital Edition of Psych Congress 2023 Brochure
